MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock and...
$50,000K
Proceeds from exercise of
pre-funded warrants
$40K
Proceeds from issuance of
common stock related to...
$25K
Proceeds from exercise of
common stock options
$5K
Net cash provided by
(used in) financing...
$43,481K
Canceled cashflow
$6,589K
Net increase
(decrease) in cash, cash...
$10,154K
Canceled cashflow
$33,327K
Payment of debt and
equity offering costs
$3,701K
Repayment of term loan
$2,057K
Tax withholding
payments on restricted...
$831K
Change in fair value of
warrant liability
$3,500K
Stock-based compensation
expense
$2,574K
Prepaid expenses and
other current assets
-$2,447K
Non-cash lease expense
$268K
Depreciation and
amortization
$21K
Net cash used in
operating activities
-$33,327K
Canceled cashflow
$8,810K
Net loss
-$38,966K
Accrued expenses and
other current...
-$2,502K
Accounts payable
-$352K
Other liabilities
-$317K
Back
Back
Cash Flow
source: myfinsight.com
SPRUCE BIOSCIENCES, INC. (SPRB)
SPRUCE BIOSCIENCES, INC. (SPRB)